Product
RO7759065
1 clinical trial
1 indication
Indication
Solid TumourClinical trial
A Phase Ia/Ib, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2027-02-28